Home › Obesity › Illinois

Pag-aaral pangklinika para sa Obesity sa Illinois

56 pag-aaral para sa Obesity ang naghahanap ng mga kalahok sa mga site sa Illinois.

Mga Lungsod sa Illinois

Opisyal na teksto ng pag-aaral (English)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Accellacare - DuPage, Lombard

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07783802

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Charter Research LLC - Chicago, Chicago
Flourish Research - Chicago, Chicago
AMR Clinical - Chicago Oak Brook, Oak Brook

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07685808

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Christie Clinic, Champaign

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Great Lakes Clinical Trials, Chicago
Clinical Investigation Spec Gurnee, Gurnee
Endeavor Health, Skokie
at 1 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Chicago Research Center, Inc, Chicago
Endeavor Health, Skokie

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Cedar Crosse Research Center, Chicago
Northwestern University, Chicago
Endeavor Health - Family Medicine Administration, Evanston
at 1 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Champaign
Research Site, Chicago

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07776509

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Rush University Medical Center, Chicago

Nagre-recruitPhase 3

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Ann and Robert Lurie Children's Hospital of Chicago, Chicago
University of Illinois at Chicago, Chicago

Nagre-recruitPhase 3

Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Rush University Medical Center, Chicago

Nagre-recruitPhase 3

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937086

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Endeavor Health, Skokie

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

NorthShore University Health System, Skokie

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Great Lakes Clinical Trials - Ravenswood, Chicago

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Chicago
Research Site, Melrose Park

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Endeavor Health-Northwest Community Healthcare, Arlington Heights
Eagle Clinical Research, Chicago
University of Chicago, Chicago
at 2 pa

Nagre-recruitPhase 3

Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Great Lakes Clinical Trials - Ravenswood, Chicago

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Great Lakes Clinical Trials - Ravenswood, Chicago

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Schaumburg

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Schaumburg

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Chicago Medical Research LLC, Hazel Crest

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Elevate Clinical Research, Gurnee
Knownwell, Schaumburg
Endeavor Health, Skokie

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351045

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

University Of Chicago, Chicago

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07571005

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Chicago Research Center, Inc, Chicago

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Great Lakes Clinical Trials - Ravenswood, Chicago

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06143956

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Walgreens - Store 11760, Oak Park

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07745504

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Skokie

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Flourish Research - Great Lakes Clinical Trials, Chicago
Endeavor Health, Skokie
Evanston Premier Healthcare Research LLC, Skokie

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Springfield

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284875

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Kailera Clinical Site, Chicago
Kailera Clinical Site, Skokie

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07284979

BRIDGE & Friends Trial

University of Illinois Chicago, Chicago

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 50 hanggang 79 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07798557

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Endeavor Health, Skokie

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07575399

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Illinois Institute of Technology, Chicago

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 21 hanggang 74 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Champaign
Research Site, Chicago

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Nagre-recruitPhase 2

Edad 7 hanggang 25 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Chicago Clinical Research Institute INC, Chicago
Univer Of Illinois at Chicago, Chicago
Eagle Clinical Research, Chicago
at 3 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07567001

Digital InteGrated Behavioral treatmeNt for Comorbid obesITy and deprEssion Among Racial and Ethnic Adults Age 50 and Older

Department of Medicine, Vitoux Program on Aging and Prevention, Chicago

Nagre-recruit

Edad 50 hanggang 74 · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06636058

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Clinical Investigation Spec Gurnee, Gurnee
Evanston Premier Hlthcr Res, Skokie

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07509307

Role of Adiposomes in Endothelial Dysfunction

University of Illinois at Chicago, Chicago

Nagre-recruit

Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05199454

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Chicago

Nagre-recruitPhase 3

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.